Article
Development and validation of a VHL-associated immune prognostic signature for clear cell renal cell carcinoma
1 Dec 2020
Abstract excerpt
BACKGROUND: VHL mutation is the most common mutation in clear cell renal cell carcinoma (ccRCC). Here, we developed and validated an immune-related signature to predict the prognosis of ccRCC with VHL mutations. METHODS: VHL mutation status and RNA expression were analysed in the TCGA datasets and our cohort. LASSO Cox analysis was performed to develop an immune-related signature. Candidate genes for the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
